Gobivaz, First Simponi Biosimilar, Wins EEA Approval
Alvotech, a global biotechnology company focused on biosimilars, and Advanz Pharma, a UK-based pharmaceutical company specializing in specialty and hospital medicines, announced that the European Commission has granted marketing authorizations for Gobivaz, Alvotech’s biosimilar to Simponi (golimumab).
ACG Launches DryPod for Moisture-Sensitive Pharmaceutical Blisters
DryPod by ACG marks an advancement for pharmaceutical manufacturers who have long grappled with limited availability, rigid technologies, and compatibility issues within existing desiccant cold-form solutions.
Steriline Marks 100th Installation in India as It Returns to CPHI & PMEC
With approximately 20 years of activity in the Indian market, Steriline has now reached 100 full line installations and aims for double-digit annual installations in 2026.
Actimed Therapeutics Announces Licensing Agreement with Mankind Pharma
Actimed Therapeutics has entered into an exclusive licensing agreement with Mankind Pharma for S-pindolol, its novel therapy in development for cancer cachexia. The partnership marks a step toward delivering the first globally approved treatment for this debilitating condition to patients across India and South Asia.
Solventum to Acquire Acera Surgical for USD 725 Million to Boost Regenerative Wound Care
Solventum, a healthcare company rooted in decades of innovation, announced a definitive agreement to acquire Acera Surgical for $725 million in cash, with an additional $125 million in milestone-based contingent payments.
Moderna Onshores Full mRNA Drug Production to USA, Expands Norwood Facility
Moderna, Inc. announced a major expansion of its U.S. manufacturing operations by bringing drug product manufacturing to its Moderna Technology Center (MTC) in Norwood, Massachusetts. With this onshoring move, the company will now manage complete end-to-end manufacturing for its mRNA medicines within the United States.
Amcor hosts industry discussion on future of logistics packaging ahead of PPWR
Amcor recently convened leading industry stakeholders to discuss the future of logistics packaging in light of the upcoming Packaging and Packaging Waste Regulation (PPWR), focusing on regulatory readiness, innovation-driven transformation, and strengthening responsible supply-chain packaging solutions.
Abbott to Acquire Exact Sciences in USD 21 Billion Deal, Entering Cancer Diagnostics Sectors
After the transaction, Exact Sciences—projected to generate more than USD 3 billion in revenue this year with high-teens organic growth—will operate as a subsidiary of Abbott.
Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health
Merck KGaA has entered into a major strategic collaboration with Valo Health to use Valo’s AI-powered human causal biology platform for discovering and developing new treatments for Parkinson’s disease and related disorders.
Nadda Urges Pharma Industry to Cut Reliance on Imported APIs
Health Minister Mansukh Mandaviya has called on India’s pharmaceutical industry to reduce dependency on imported active pharmaceutical ingredients (APIs) and focus on strengthening domestic manufacturing capability. He emphasised that enhancing self-reliance in API production is vital for national health security and economic resilience.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy